• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

采用毫秒级微流控混合技术,从下至上设计并合成具有水性和甘油三酯核的极限尺寸脂质纳米颗粒体系。

Bottom-up design and synthesis of limit size lipid nanoparticle systems with aqueous and triglyceride cores using millisecond microfluidic mixing.

机构信息

Department of Biochemistry and Molecular Biology, Faculty of Medicine, University of British Columbia, BC, Canada.

出版信息

Langmuir. 2012 Feb 21;28(7):3633-40. doi: 10.1021/la204833h. Epub 2012 Feb 9.

DOI:10.1021/la204833h
PMID:22268499
Abstract

Limit size systems are defined as the smallest achievable aggregates compatible with the packing of the molecular constituents in a defined and energetically stable structure. Here we report the use of rapid microfluidic mixing for the controlled synthesis of two types of limit size lipid nanoparticle (LNP) systems, having either polar or nonpolar cores. Specifically, limit size LNP consisting of 1-palmitoyl, 2-oleoyl phosphatidylcholine (POPC), cholesterol and the triglyceride triolein were synthesized by mixing a stream of ethanol containing dissolved lipid with an aqueous stream, employing a staggered herringbone micromixer. Millisecond mixing of aqueous and ethanol streams at high flow rate ratios (FRR) was used to rapidly increase the polarity of the medium, driving bottom-up synthesis of limit size LNP systems by spontaneous assembly. For POPC/triolein systems the limit size structures consisted of a hydrophobic core of triolein surrounded by a monolayer of POPC where the diameter could be rationally engineered over the range 20-80 nm by varying the POPC/triolein ratio. In the case of POPC and POPC/cholesterol (55/45; mol/mol) the limit size systems achieved were bilayer vesicles of approximately 20 and 40 nm diameter, respectively. We further show that doxorubicin, a representative weak base drug, can be efficiently loaded and retained in limit size POPC LNP, establishing potential utility as drug delivery systems. To our knowledge this is the first report of stable triglyceride emulsions in the 20-50 nm size range, and the first time vesicular systems in the 20-50 nm size range have been generated by a scalable manufacturing method. These results establish microfluidic mixing as a powerful and general approach to access novel LNP systems, with both polar or nonpolar core structures, in the sub-100 nm size range.

摘要

限域尺寸体系被定义为与分子组成在限定和稳定结构中的堆积相容的最小可达聚集体。在这里,我们报告了使用快速微流混合来控制合成两种类型的限域尺寸脂质纳米颗粒(LNP)系统,它们具有极性或非极性核心。具体而言,由 1-棕榈酰基、2-油酰基磷脂酰胆碱(POPC)、胆固醇和三油酸甘油酯组成的限域尺寸 LNP 是通过将含有溶解脂质的乙醇流与水相流混合,使用交错人字形微混合器来合成的。在高流速比(FRR)下毫秒级混合水相和乙醇流,可快速增加介质的极性,通过自发组装驱动限域尺寸 LNP 系统的自下而上合成。对于 POPC/三油酸甘油酯系统,限域尺寸结构由三油酸甘油酯的疏水性核心组成,其周围是一层 POPC,通过改变 POPC/三油酸甘油酯的比例,可以合理地将直径设计在 20-80nm 的范围内。对于 POPC 和 POPC/胆固醇(55/45;摩尔/摩尔),所获得的限域尺寸系统分别为约 20nm 和 40nm 直径的双层囊泡。我们进一步表明,阿霉素,一种代表性的弱碱性药物,可以有效地负载和保留在限域尺寸的 POPC LNP 中,为作为药物传递系统建立了潜在的应用。据我们所知,这是首次在 20-50nm 范围内报道稳定的甘油三酯乳液,也是首次通过可扩展的制造方法生成 20-50nm 范围内的囊泡系统。这些结果确立了微流混合作为一种强大而通用的方法,可在亚 100nm 范围内获得具有极性或非极性核心结构的新型 LNP 系统。

相似文献

1
Bottom-up design and synthesis of limit size lipid nanoparticle systems with aqueous and triglyceride cores using millisecond microfluidic mixing.采用毫秒级微流控混合技术,从下至上设计并合成具有水性和甘油三酯核的极限尺寸脂质纳米颗粒体系。
Langmuir. 2012 Feb 21;28(7):3633-40. doi: 10.1021/la204833h. Epub 2012 Feb 9.
2
Production of limit size nanoliposomal systems with potential utility as ultra-small drug delivery agents.具有作为超小型药物递送剂潜在用途的极限尺寸纳米脂质体系统的制备。
J Liposome Res. 2016;26(2):96-102. doi: 10.3109/08982104.2015.1025411. Epub 2015 Apr 9.
3
Rapid synthesis of lipid nanoparticles containing hydrophobic inorganic nanoparticles.快速合成含有疏水性无机纳米颗粒的脂质纳米颗粒。
Nanoscale. 2017 Sep 21;9(36):13600-13609. doi: 10.1039/c7nr03272b.
4
Microfluidic directed formation of liposomes of controlled size.微流控法可控尺寸脂质体的定向形成
Langmuir. 2007 May 22;23(11):6289-93. doi: 10.1021/la070051a. Epub 2007 Apr 24.
5
Microfluidic directed self-assembly of liposome-hydrogel hybrid nanoparticles.微流控引导的脂质体-水凝胶杂化纳米颗粒的自组装。
Langmuir. 2010 Jul 6;26(13):11581-8. doi: 10.1021/la100879p.
6
Polydispersity characterization of lipid nanoparticles for siRNA delivery using multiple detection size-exclusion chromatography.使用多种检测尺寸排阻色谱法对用于 siRNA 传递的脂质纳米粒进行多分散性表征。
Anal Chem. 2012 Jul 17;84(14):6088-96. doi: 10.1021/ac3007768. Epub 2012 Jul 2.
7
Microfluidic Mixing: A General Method for Encapsulating Macromolecules in Lipid Nanoparticle Systems.微流控混合:一种在脂质纳米颗粒系统中封装大分子的通用方法。
J Phys Chem B. 2015 Jul 16;119(28):8698-706. doi: 10.1021/acs.jpcb.5b02891. Epub 2015 Jul 7.
8
The Effect of Size and Charge of Lipid Nanoparticles Prepared by Microfluidic Mixing on Their Lymph Node Transitivity and Distribution.微流控混合法制备的脂质纳米粒子的大小和电荷对其淋巴结转移和分布的影响。
Mol Pharm. 2020 Mar 2;17(3):944-953. doi: 10.1021/acs.molpharmaceut.9b01182. Epub 2020 Feb 5.
9
Understanding the formation mechanism of lipid nanoparticles in microfluidic devices with chaotic micromixers.理解具有混沌微混合器的微流控装置中脂质纳米颗粒的形成机制。
PLoS One. 2017 Nov 28;12(11):e0187962. doi: 10.1371/journal.pone.0187962. eCollection 2017.
10
Antisolvent precipitation of lipid nanoparticles in microfluidic systems - A comparative study.微流控系统中脂质纳米粒的抗溶剂沉淀——比较研究。
Int J Pharm. 2020 Apr 15;579:119167. doi: 10.1016/j.ijpharm.2020.119167. Epub 2020 Feb 20.

引用本文的文献

1
Standardizing a Protocol for Streamlined Synthesis and Characterization of Lipid Nanoparticles to Enable Preclinical Research and Education.标准化脂质纳米颗粒简化合成与表征方案以推动临床前研究与教育
bioRxiv. 2025 Aug 1:2025.07.31.667476. doi: 10.1101/2025.07.31.667476.
2
Rational design of lipid nanoparticles for enabling gene therapies.用于实现基因治疗的脂质纳米颗粒的合理设计。
Mol Ther Methods Clin Dev. 2025 Jun 18;33(3):101518. doi: 10.1016/j.omtm.2025.101518. eCollection 2025 Sep 11.
3
Diffusiophoresis of a Weakly Charged Dielectric Fluid Droplet in a Cylindrical Pore.
圆柱形孔隙中弱带电介电流体微滴的扩散泳动
Micromachines (Basel). 2025 Jun 13;16(6):707. doi: 10.3390/mi16060707.
4
Microfluidic Production of Exosome-Mimicking Lipid Nanoparticles for Enhanced RNA Delivery: Role of Exosomal Proteins.用于增强RNA递送的外泌体模拟脂质纳米颗粒的微流体制备:外泌体蛋白的作用
ACS Appl Mater Interfaces. 2025 Jul 23;17(29):41666-41679. doi: 10.1021/acsami.5c06927. Epub 2025 Jun 16.
5
Multiparametric functional characterization of individual lipid nanoparticles using surface-sensitive light-scattering microscopy.使用表面敏感光散射显微镜对单个脂质纳米颗粒进行多参数功能表征。
Proc Natl Acad Sci U S A. 2025 May 27;122(21):e2426601122. doi: 10.1073/pnas.2426601122. Epub 2025 May 22.
6
A Post-Encapsulation Method for the Preparation of mRNA-LNPs via the Nucleic Acid-Bridged Fusion of mRNA-Free LNPs.一种通过无mRNA脂质纳米颗粒的核酸桥接融合制备mRNA-脂质纳米颗粒的封装后方法。
Nano Lett. 2025 Apr 23;25(16):6445-6453. doi: 10.1021/acs.nanolett.4c06643. Epub 2025 Apr 12.
7
A synthetic model of bioinspired liposomes to study cancer-cell derived extracellular vesicles and their uptake by recipient cells.一种用于研究癌细胞衍生的细胞外囊泡及其被受体细胞摄取的仿生脂质体合成模型。
Sci Rep. 2025 Mar 11;15(1):8430. doi: 10.1038/s41598-025-91873-5.
8
Fabrication of Biomimetic Hybrid Liposomes via Microfluidic Technology: Homotypic Targeting and Antitumor Efficacy Studies in Glioma Cells.通过微流控技术制备仿生混合脂质体:在胶质瘤细胞中的同型靶向和抗肿瘤功效研究
Int J Nanomedicine. 2024 Dec 8;19:13217-13233. doi: 10.2147/IJN.S489872. eCollection 2024.
9
Applications of microfluidics in mRNA vaccine development: A review.微流控技术在mRNA疫苗研发中的应用:综述
Biomicrofluidics. 2024 Nov 14;18(6):061502. doi: 10.1063/5.0228447. eCollection 2024 Dec.
10
Charge-Stabilized Nanodiscs as a New Class of Lipid Nanoparticles.电荷稳定纳米盘作为一类新型脂质纳米颗粒
Adv Mater. 2024 Dec;36(52):e2408307. doi: 10.1002/adma.202408307. Epub 2024 Nov 14.